Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
Option to license revenue	$ 194	$ 0	$ 194	$ 0
Total revenues	194	0	194	0
Cost and expenses:
Research and development	81	580	230	1,491
General and administrative	1,241	2,131	4,094	6,361
Impairment loss	0	3,304	0	3,304
Total cost and expenses	1,322	6,015	4,324	11,156
Loss from operations	(1,128)	(6,015)	(4,130)	(11,156)
Other income, net
Interest income	42	107	180	257
Gain from settlement of account payable	363	0	363	0
Total other income, net	405	107	543	257
Net loss from continuing operations	(723)	(5,908)	(3,587)	(10,899)
Discontinued operations:
Gain from discontinued operations	0	13,474	0	7,330
Net gain (loss)	$ (723)	$ 7,566	$ (3,587)	$ (3,569)
Net gain (loss) per share - basic and diluted
Net loss per share from continuing operations - basic	$ (0.29)	$ (2.43)	$ (1.43)	$ (4.74)
Net gain (loss) per share from discontinued operations - basic	0	5.53	0	3.19
Basic net gain (loss) per share	(0.29)	3.1	(1.43)	(1.55)
Net loss per share from continuing operations - diluted	(0.29)	(2.12)	(1.43)	(4.74)
Net gain per share from discontinued operations - diluted	0	4.84	0	3.19
Diluted net gain (loss) per share	$ (0.29)	$ 2.72	$ (1.43)	$ (1.55)
Weighted average shares used in calculating:
Basic shares	2,526	2,435	2,510	2,299
Diluted shares	2,526	2,786	2,510	2,299
Other comprehensive loss:
Net Income (Loss)	$ (723)	$ 7,566	$ (3,587)	$ (3,569)
Other comprehensive loss:
Foreign currency translation adjustment gain (loss)	0	(2)	(6)	2
Comprehensive loss	$ (723)	$ 7,564	$ (3,593)	$ (3,567)